685533-95-3 Usage
Class
Substituted aniline
It is a derivative of aniline, which is a basic class of organic compounds used in the production of dyes, pharmaceuticals, and agrochemicals.
Trifluoromethyl group
(CF3)
A fluorinated alkyl group consisting of a carbon atom bonded to three fluorine atoms, which can influence the compound's reactivity, stability, and lipophilicity.
Dimethylaminoethoxy group
(N(CH3)2OCH2)
An alkoxyamine group formed by the attachment of a dimethylamino group (N(CH3)2) to an ethoxy group (OCH2), which can contribute to the compound's solubility and reactivity.
5. Valuable intermediate
This compound serves as an important building block in the synthesis of various pharmaceuticals and agrochemicals due to its unique functional groups.
6. Health and safety risks
Proper handling and precautions are necessary when working with this compound, as it may pose potential hazards to human health and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 685533-95-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,5,5,3 and 3 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 685533-95:
(8*6)+(7*8)+(6*5)+(5*5)+(4*3)+(3*3)+(2*9)+(1*5)=203
203 % 10 = 3
So 685533-95-3 is a valid CAS Registry Number.
685533-95-3Relevant articles and documents
BISARYLUREA DERIVATIVES
-
Page/Page column 183, (2010/02/13)
The present invention relates to bisarylurea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
SEMICARBAZIDE DERIVATIVES AS KINASE INHIBITORS
-
Page/Page column 217-218; 219, (2008/06/13)
The present invention relates to semicarbazide derivatives of formula I, the use of the compounds of formula I as inhibitors of one or more kinases, the use of the compounds of formula I for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
METHYLENE UREA DERIVATIVES
-
Page 312, (2008/06/13)
The present invention relates to methylene urea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
